论文部分内容阅读
目的:探讨中西医结合治疗对于乳腺癌患者手术后的治疗效果及临床应用价值。方法:选择100例乳腺癌手术后患者为研究对象,按照随机数字表法分为对照组(50例)和观察组(50例),对照组患者给予常规术后化疗等对症处理,观察组患者在对照组的基础上给予中西医结合治疗。比较两组患者治疗期间药物不良反应、术后生活质量的影响。结果:观察组患者术后治疗期间恶心呕吐4.0%、肝功能损伤4.0%、脱发6.0%、骨髓抑制2.0%的发生率显著低于对照组的恶心呕吐14.0%、肝功能损伤10.0%、脱发18.0%、骨髓抑制8.0%,差异有统计学意义(P<0.05),具有可比性。观察组患者的术后生活质量统计分析中,优为74.0%,明显高于对照组患者的62.0%,差异有统计学意义(P<0.05),具有可比性。观察组患者的术后生活质量差为0.0%,明显低于对照组患者的8.0%,差异有统计学意义(P<0.05),具有可比性。结论:中西医结合治疗在乳腺癌患者术后的治疗中,可以有效地降低患者术后治疗期间药物不良反应等各项术后治疗的并发症发生率,有效的提高了患者的术后治疗效果,改善了患者的术后愈后情况。而且中西医结合治疗有效地提高了将患者的术后生活质量情况,具有较好的临床应用价值,值得临床上进一步推广使用。
Objective: To investigate the therapeutic effect and clinical value of integrated traditional Chinese and western medicine on postoperative patients with breast cancer. Methods: 100 cases of breast cancer patients were selected as the research object, divided into control group (50 cases) and observation group (50 cases) according to the random number table. Patients in the control group were given conventional postoperative chemotherapy and other symptomatic treatment. Patients in the observation group In the control group on the basis of Integrative Medicine. The adverse drug reactions and postoperative quality of life were compared between the two groups during treatment. Results: The incidence of postoperative nausea and vomiting 4.0%, liver dysfunction 4.0%, alopecia 6.0% and myelosuppression 2.0% in the observation group was significantly lower than that in the control group 14.0%, hepatic injury 10.0% and hair loss 18.0 %, Myelosuppression 8.0%, the difference was statistically significant (P <0.05), comparable. In the observation group, the postoperative quality of life was 74.0%, which was significantly higher than that of the control group (62.0%), with statistical significance (P <0.05). The postoperative quality of life of the observation group was 0.0%, which was significantly lower than that of the control group (8.0%), the difference was statistically significant (P <0.05), comparable. Conclusion: Integrative Medicine in the treatment of breast cancer patients after surgery, patients can effectively reduce the postoperative treatment of adverse drug reactions and other postoperative complications of the incidence of complications, and effectively improve the patient’s postoperative treatment , To improve the patient’s postoperative recovery situation. And the combination of traditional Chinese and Western medicine treatment effectively improves the patient’s postoperative quality of life, with good clinical value, it is worth further promotion of clinical use.